Bavarian Nordic A/S (OTCMKTS:BVNRY) Stock Crosses Below Two Hundred Day Moving Average of $7.60

Bavarian Nordic A/S (OTCMKTS:BVNRY) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $7.60 and traded as low as $7.02. Bavarian Nordic A/S shares last traded at $7.03, with a volume of 722 shares.

Bavarian Nordic A/S Stock Down 1.5 %

The stock has a market cap of $1.65 billion, a price-to-earnings ratio of 7.40 and a beta of 1.50. The company has a 50 day simple moving average of $7.66 and a 200 day simple moving average of $7.60.

Bavarian Nordic A/S (OTCMKTS:BVNRY) last announced its earnings results on Wednesday, March 6th. The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.44 by $0.12. Bavarian Nordic A/S had a return on equity of 0.07% and a net margin of 20.80%. The business had revenue of $353.27 million for the quarter, compared to analysts’ expectations of $340.71 million. As a group, analysts predict that Bavarian Nordic A/S will post 0.57 earnings per share for the current fiscal year.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.